ClassID:

94439

C07D233/96 - CPC Classification

Classification description:

Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having three double bonds between ring members or between ring members and non-ring members

Recent Application in this class:
#1
20260149045
2026-05-28

COMPOUND, ELECTROLYTE FOR RECHARGEABLE LITHIUM BATTERY, AND RECHARGEABLE LITHIUM BATTERY INCLUDING THE SAME

#2
20260124202
2026-05-07

CD97 AND GSDME INTERACTION INHIBITOR HAVING ANTI-TUMOR ACTIVITY AND APPLICATION THEREOF

#3
20260090268
2026-03-26

ORGANIC COMPOUND, LIGHT-EMITTING DEVICE INCLUDING THE ORGANIC COMPOUND, ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE, AND ELECTRONIC EQUIPMENT INCLUDING THE ELECTRONIC APPARATUS

#4
20260000631
2026-01-01

SYNTHETIC RETINOIDS FOR USE IN RAR ACTIVATION

#5
20250223307
2025-07-10

MDM2/MDMX DOUBLE-TARGET INHIBITOR COMPOUND, PRODRUG, PHARMACEUTICAL COMPOSITION, AND PREPARATION METHOD THEREFOR AND USE THEREOF

#6
20250115563
2025-04-10

MODULATORS OF THE INTEGRATED STRESS PATHWAY

#7
20250089563
2025-03-13

LIGHT-EMITTING DEVICE INCLUDING AMINE-CONTAINING COMPOUND, ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE, AND THE AMINE-CONTAINING COMPOUND

#8
20250008959
2025-01-09

HERBICIDES AND USE THEREOF

#9
20240425547
2024-12-26

PSMA Imaging Agents

#10
20240415815
2024-12-19

IONIC-LIQUID-BASED FORMULATIONS FOR THE PREVENTION OR TREATMENT OF NEUROLOGICAL DISEASES

#11
20240409580
2024-12-12

PSMA Imaging Agents

#12
20240317690
2024-09-26

LITHIUM SALTS OF CYANO-SUBSTITUTED IMIDAZOLE FOR LITHIUM ION BATTERIES

#13
20240174618
2024-05-30

SUBSTITUTED (2-HETEROARYLOXYPHENYL)SULFONATES, SALTS THEREOF AND THEIR USE AS HERBICIDAL AGENTS

#14
20240025860
2024-01-25

SARS-COV-2 INHIBITORS FOR TREATING CORONAVIRUS INFECTIONS

#15
20230286956
2023-09-14

1-ALKYL-5-ARYLIDENE-2-SELENOXOIMIDAZOLIDINE-4-ON AND DERIVATIVE THEREOF, PREPARATION METHOD THEREFOR, AND COMPOSITION COMPRISING SAME FOR PREVENTING, ALLEVIATING OR TREATING NEURODEGENERATIVE DISEASES

#16
20230192624
2023-06-22

SARS-CoV-2 inhibitors for treating coronavirus infections

#17
20230144871
2023-05-11

MODULATORS OF THE INTEGRATED STRESS PATHWAY

#18
20230141569
2023-05-11

FLUORESCENT DYE, AND PREPARATION METHOD AND USES THEREOF

#19
20230129364
2023-04-27

PYRROLIDINE DERIVATIVE, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING BETA-AMYLOID OR TAU PROTEIN-ASSOCIATED DISEASES CONTAINING SAME

#20
20220347299
2022-11-03

FLUORESCENT SYSTEMS FOR BIOLOGICAL IMAGING AND USES THEREOF

#21
20220144783
2022-05-12

SYNTHETIC RETINOIDS FOR USE IN RAR ACTIVATION

#22
20220081423
2022-03-17

THERAPEUTIC COMPOUNDS AND METHODS OF USE THEREOF

#23
20210340110
2021-11-04

Chemotherapeutic oxazolone derivatives and pharmaceutical compositions thereof

#24
20210230123
2021-07-29

INHIBITORS OF ALPHA-AMINO-BETA-CARBOXYMUCONIC ACID SEMIALDEHYDE DECARBOXYLASE

#25
20210139434
2021-05-13

Anticancer compounds, pharmaceutical compositions thereof, and a method of treating cancer

#26
20210032286
2021-02-04

PSMA Imaging Agents

#27
20210024574
2021-01-28

PSMA imaging agents

#28
20200377549
2020-12-03

PSMA imaging agents

#29
20200361881
2020-11-19

MODULATORS OF THE INTEGRATED STRESS PATHWAY

#30
20200248069
2020-08-06

FLUORESCENT PROBE, PREPARATION METHOD THEREFOR AND USE THEREOF

#31
20200207721
2020-07-02

Inhibitors of alpha-amino-beta-carboxymuconic acid semialdehyde decarboxylase

#32
20200190045
2020-06-18

Ferroportin inhibitors and methods of use

#33
20200131121
2020-04-30

USP30 inhibitors

#34
20200087262
2020-03-19

Lithium salts of cyano-substituted imidazole for lithium ion batteries

#35
20200024246
2020-01-23

POGOSTONE DERIVATIVES AND METHODS OF USING THE SAME

#36
20190263786
2019-08-29

Therapeutic compounds and methods of use thereof

#37
20190194142
2019-06-27

Adenosine monophosphate-activated protein kinase agonist

#38
20190185434
2019-06-20

Coupled recognition/detection system for in vivo and in vitro use

#39
20180258134
2018-09-13

PSMA imaging agents

#40
20180072682
2018-03-15

Compositions for the treatment of fibrosis and fibrosis-related conditions

#41
20170362185
2017-12-21

Inhibitors of alpha-amino-beta-carboxymuconic acid semialdehyde decarboxylase

#42
20170320863
2017-11-09

Herbicidal compounds

#43
20160304555
2016-10-20

PSMA imaging agents

#44
20160229831
2016-08-11

SUBSTITUTED 3-PHENYLPROPYLAMINE DERIVATIVES FOR THE TREATMENT OF OPHTHALMIC DISEASES AND DISORDERS

#45
20160130240
2016-05-12

Aryl sulfide derivatives and aryl sulfoxide derivatives as acaricides and insecticides

#46
20160102065
2016-04-14

Compound having skin-whitening, anti-oxidizing and PPAR activities and medical use thereof

#47
20160060226
2016-03-03

Inhibitors of α-amino-β-carboxymuconic acid semialdehyde decarboxylase

#48
20150065728
2015-03-05

Benzylidene azolidine derivative or salt thereof

#49
20140370418
2014-12-18

Monomers and polymers carrying imidazole and benzimidazole groupings, and proton exchange membrane containing the same for the production of a fuel cell

#50
20140357864
2014-12-04

Process for the preparation of a statin precursor

#51
20140073639
2014-03-13

INHIBITION OF ANTIMICROBIAL TARGETS WITH REDUCED POTENTIAL FOR RESISTANCE

#52
20130234427
2013-09-12

Use of aryl or heteroaryl substituted dithiolene metal complexes as IR absorbers

#53
20130225596
2013-08-29

Heterocyclic derivative and pharmaceutical composition comprising the same

#54
20130040951
2013-02-14

PROPHYLACTIC OR THERAPEUTIC AGENT FOR CANCER

#55
20130037782
2013-02-14

Heterocyclic compound and organic light-emitting diode including the same

#56
20120252699
2012-10-04

Coupled recognition/detection system for in vivo and in vitro use

#57
20120196864
2012-08-02

PROPHYLACTIC OR THERAPEUTIC AGENT FOR CANCER

#58
20120157688
2012-06-21

IMIDAZOLIUM MONOCARBOXYLATE SALT AND METHOD FOR PREPARATION THEREOF

#59
20110165632
2011-07-07

Process for the preparation of an orexin receptor antagonist

#60
20100256147
2010-10-07

BIARYL ACETAMIDE DERIVATIVES AS MODULATORS OF THE KINASE CASCADE FOR THE TREATMENT OF HEARING LOSS, OSTEOPOROSIS AND CELL PROLIFERATION DISORDERS

#61
20100216855
2010-08-26

Imidazolone derivatives, method for the preparation thereof and biological applications

#62
20100204219
2010-08-12

AROMATIC 1,4-DI-CARBOXYLAMIDES AND THEIR USE

#63
20100151351
2010-06-17

Monomers and polymers carrying imidazole and benzimidazole groupings, and proton exchange membrane containing the same for the production of a fuel cell

#64
20090160328
2009-06-25

ORGANIC ELECTROLUMINESCENCE MATERIAL AND ELEMENT USING THE SAME

#65
20080220286
2008-09-11

Dinaphthyl ethylene derivativce, process for preparing it, film prepared from it, and OLED including the film

#66
20070155750
2007-07-05

Integrin-binding small molecules

#67
20070060584
2007-03-15

Biaryl substituted thiazoles, oxazoles and imidazoles as sodium channel blockers

#68
20070032536
2007-02-08

Compounds, compositions and methods

#69
20070015757
2007-01-18

Novel Glucagon Antagonists/Inverse Agonists

#70
20060124017
2006-06-15

New compounds, a process for their preparation and their use as dyes and pigments

#71
20060004103
2006-01-05

Method for producing lysine derivative

#72
20060004059
2006-01-05

Substituted heterocycles for the treatment of diabetes and other diseases

#73
20050191229
2005-09-01

Fullerene compounds

#74
20050153968
2005-07-14

Monocyclic -Aryl hydantoin modulators of androgen receptor function

#75
20050148645
2005-07-07

2-guanidinylimidazolidinedione compounds and methods of making and using thereof

#76
20050090630
2005-04-28

Supported group 8-10 transition metal olefin polymerization catalysts

#77
20050070581
2005-03-31

Imidazolidinedione derivatives for the treatment of diabetes and other diseases

#78
20050004153
2005-01-06

Spiro-hydantoin compounds useful as anti-inflammatory agents

#79
18379835
2024-02-20

Benzylidene derivatives of fenobam as anti-inflammatory agents

#80
18375672
2024-05-14

Oxoimidazolidine derivatives as anti-tubercular agents

#81
18134693
2024-02-06

N2,N4-disubstituted pyrimidine-2,4-diamine compounds as antibacterial agents

#82
17377530
2021-11-16

Anti-cancer compounds having oxazolone derivation

#83
16985620
2020-11-24

Pharmaceutical composition and method of treating cancer